This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: A. Nattermann & Cie Gmbh, Daiichi Pharmaceutical Co., Ltd., Other. Active years: 1996-2010.
Company Filing History:
1 out of 94 
1 out of 200 
1 out of 834,411 Years Active: 1996-2010
Title: Hiroyuki Masayasu: Innovator in Pharmaceutical Research
Introduction
Hiroyuki Masayasu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of drugs aimed at treating neurodegenerative diseases. With a total of 3 patents to his name, Masayasu's work has garnered attention for its innovative approaches to complex medical challenges.
Latest Patents
Masayasu's latest patents include groundbreaking inventions that focus on enhancing the efficacy of thioredoxin reductase. One of his notable patents describes a substrate for thioredoxin reductase, which comprises a compound represented by a specific general formula. This substrate is designed to be reduced by thioredoxin reductase in the presence of NADPH, thereby enhancing the enzyme's peroxidase activity. Another significant patent is directed towards a preventive or therapeutic drug for Alzheimer's disease. This drug contains 2-phenyl-1,2-benzisoselenazol-3(2H)-one as its active ingredient, which has shown potential in reducing neuron toxicity induced by beta-amyloid protein.
Career Highlights
Throughout his career, Hiroyuki Masayasu has worked with notable companies, including Daiichi Pharmaceutical Co., Ltd. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic advancements.
Collaborations
Masayasu has collaborated with esteemed colleagues, including Kazuhisa Kodama and Atsushi Hirayama. These collaborations have fostered a productive environment for research and innovation, leading to the development of impactful pharmaceutical solutions.
Conclusion
Hiroyuki Masayasu's contributions to pharmaceutical research exemplify the importance of innovation in addressing complex health challenges. His patents reflect a commitment to improving therapeutic options for diseases such as Alzheimer's. Through his work, Masayasu continues to inspire future generations of inventors and researchers.